한국지질동맥경화학회 학술대회

[OP1-1] Improved survival and in vivo cholesterol-lowering efficacy of microencapsulated Lactobacillus plantarum LAB12

[OP1-2] Lipid accumulation product and visceral adiposity indices as markers of hyperuricemia and gout: a meta-analysis of 575,000 patients

[OP1-3] Distinct vascular targets of metabolic and kidney dysfunction in adults without advanced

[OP1-4] A randomized, double-blind, placebo-controlled, crossover trial to comparatively evaluate the effects of magnesium hydride (MgH2) on endothelial function: a pilot study

[OP1-5] Association of dietary sodium-to-potassium ratio with triglyceride-glucose index and metabolic syndrome risk in Korean adults: using data from the 2022-2023 Korea National Health and Nutrition Examination Survey

[OP1-6] A newly developed grain-based cereal product for glycemic spike management: effects on glycemic index, glycemic load, and postprandial glucose responses

[OP1-7] Nutraceutical modulation of the oral-vascular axis: emerging therapeutic strategies for periodontitis-associated atherosclerosis

[OP2-1] Renal lipidomic profiling reveals boerhaavia diffusa extract ameliorates saturated fatty acid lipotoxicity and mitochondrial decay independent of systemic adiposity

[OP2-2] Extrahepatic bile acid synthesis reprograms multiorgan cholesterol flux in cardiovascular disease

[OP2-3] Prdx3 deficiency triggers cGAS-STING signaling pathway induced vascular smooth muscle cell senescence and phenotypic switching in abdominal aortic aneurysm

[OP2-4] Sphingosine-1-phosphate receptor 1 deletion in smooth muscle cells protects against atherosclerosis in apoE-deficient mice by reducing lipid droplet formation

[OP2-5] Senolytic therapy attenuates atherosclerosis and metabolic dysfunction by targeting cellular senescence in western diet-fed Ldlr KO mice

[OP2-6] The role of LGI3 in adipocytes and macrophages in atherosclerosis

[OP2-7] Cyclic induction of OSKM expression mitigates atherosclerosis through vascular anti-inflammatory remodeling independent of systemic metabolic effects

[OP2-8] Extracellular vesicles produced by M2-polarized macrophages drive atherosclerosis regression by reprograming Ly-6Chi monocytes & enhancing efferocytosis

[OP3-1] Residual risk of remnant cholesterol in patients treated to LDL-C goal: a landmark analysis of the RACING trial

[OP3-2] Lower cardiovascular event risk with bempedoic acid versus ezetimibe in statin-intolerant atherosclerotic cardiovascular disease (ASCVD): a 3,540-patient TriNetX analysis

[OP3-3] Age-dependent association of atherogenic dyslipidemia with incident cardiovascular disease: a nationwide Korean cohort study

[OP3-4] Deep learning analysis of BMI, metabolic risk factors, and sex hormones in U.S. women: a NHANES study

[OP3-5] Prevalence of high inflammatory risk in atherosclerotic cardiovascular disease with and without chronic kidney disease: findings from POSEIDON - a global cross-sectional prevalence study

[OP3-6] Real-world efficacy and tolerability of inclisiran in Malaysian patients with atherosclerotic cardiovascular disease: a single-centre experience

[OP3-7] A Korean multidimensional social determinants of health index identifies individuals at elevated risk of severe coronary artery calcification: evidence from the CMERC cohort

[OP3-8] Efficacy and safety of enlicitide decanoate, an oral macrocyclic peptide inhibitor of PCSK9, compared with bempedoic acid, ezetimibe, or bempedoic acid co-administered with ezetimibe in statin-treated adults with hypercholesterolemia: phase 3 CORALreef AddOn trial